Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
Professor Li Zhang, Department of Mechanical and Automation Engineering, The Chinese University of Hong Kong, and co-authors, have published research in Advanced Functional Materials on a polyvinyl alcohol…
A recent publication in Interventional Pain Medicine, authored by Rohan Jotwani, MD, MBA, of Brigham and Women’s Hospital, Harvard Medical School in Boston, MA, and colleagues, demonstrates the…
